Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC. Radiology and Oncology, v. 59, n. 4, p. 617–623, 16 Dec.2025.